Elan - Pharma manufacturing consent decrees

Start Date: 2001
Financial penalties: none
End Date: 2004

Nonconformance issues at a Georgia facility prompted this consent decree, which is comparatively mild given its three-year timeframe and lack of financial penalty. Issues included inadequate equipment maintenance and lack of testing and final validation.

Elan - Pharma manufacturing consent decrees
Read more on